TITLE:
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

CONDITION:
Mycobacterium Avium-Intracellulare Infection

INTERVENTION:
Nelfinavir mesylate

SUMMARY:

      The purpose of this study is to see if it is safe and effective to give Viracept to AIDS
      patients who are being treated for MAC.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV infection

          -  New diagnosis of MAC bacteremia and < 7 days of therapy.

        Prior Medication:

        Allowed:

        Patients no more than 7 days of therapy for MAC disease.

        Exclusion Criteria

        Prior Medication:

        Excluded:

        Prior therapy (or less than 2 weeks) with protease inhibitors other than saquinavir.
      
